Expert Opinion on Biological Therapy,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 16, 2024
The
remarkable
ability
of
human
pluripotent
stem
cells
(hPSCs)
to
differentiate
into
specialized
the
body
emphasizes
their
immense
potential
in
treating
various
diseases.
Advances
hPSC
technology
are
paving
way
for
personalized
and
allogeneic
cell-based
therapies.
first-in-human
studies
showed
improved
treatment
diseases
with
no
adverse
effects,
which
encouraged
industrial
production
this
type
medicine.
To
ensure
quality,
safety
efficacy
hPSC-based
products
throughout
life
cycle,
it
is
important
monitor
control
clinical
translation
through
good
practices
(GxP)
regulations.
Understanding
these
rules
advance
will
help
that
development
hPSC-derived
widespread
implementation
feasible
progresses
rapidly.
MedComm,
Journal Year:
2023,
Volume and Issue:
4(4)
Published: June 17, 2023
Abstract
Regeneration
is
a
complex
process
affected
by
many
elements
independent
or
combined,
including
inflammation,
proliferation,
and
tissue
remodeling.
Stem
cells
class
of
primitive
with
the
potentiality
differentiation,
regenerate
self‐replication,
multidirectional
immunomodulatory
functions.
their
cytokines
not
only
inextricably
linked
to
regeneration
ectodermal
skin
tissues,
but
also
can
be
used
for
treatment
variety
chronic
wounds.
produce
exosomes
in
paracrine
manner.
cell
play
an
important
role
regeneration,
repair,
accelerated
wound
healing,
biological
properties
which
are
similar
stem
cells,
while
safer
more
effective.
Skin
bone
tissues
critical
organs
body,
essential
sustaining
life
activities.
The
weak
repairing
ability
leads
pronounced
impact
on
quality
patients,
could
alleviated
treatment.
However,
there
obstacles
that
trough
improved
bioavailability.
This
paper
summarizes
applications
mechanisms
healing.
We
propose
new
ways
utilizing
through
different
nanoformulations,
liposomes
nanoliposomes,
polymer
micelles,
microspheres,
hydrogels,
scaffold
microneedles,
improve
use
healing
regeneration.
Future Pharmacology,
Journal Year:
2024,
Volume and Issue:
4(2), P. 352 - 379
Published: April 30, 2024
Neurodegenerative
disorders
entail
a
progressive
loss
of
neurons
in
cerebral
and
peripheral
tissues,
coupled
with
the
aggregation
proteins
exhibiting
altered
physicochemical
properties.
Crucial
to
these
conditions
is
gradual
degradation
central
nervous
system,
manifesting
as
impairments
mobility,
aberrant
behaviors,
cognitive
deficits.
Mechanisms
such
proteotoxic
stress,
neuroinflammation,
oxidative
programmed
cell
death
contribute
ongoing
dysfunction
demise
neurons.
Presently,
neurodegenerative
diseases
lack
definitive
cures,
available
therapies
primarily
offer
palliative
relief.
The
integration
nanotechnology
into
medical
practices
has
significantly
augmented
both
treatment
efficacy
diagnostic
capabilities.
Nanoparticles,
capable
traversing
blood–brain
barrier,
hold
considerable
potential
for
diagnosing
treating
brain
pathologies.
By
combining
gene
therapy
nanotechnology,
therapeutic
effectiveness
against
can
be
substantially
enhanced.
Recent
advancements
nano-biomaterial-based
methodologies
have
fortified
existing
approaches
neural
stem
(NSC)
differentiation
therapies.
NSC-targeting
technologies
promising,
potentially
safe
method
diseases.
This
review
endeavors
summarize
current
insights
perspectives
on
nanotechnology-driven
innovations
disorders,
particular
emphasis
Alzheimer’s
Parkinson’s
disease.
ABSTRACT
Background
Adenosine
deaminase
action
on
RNA
1
(ADAR1)
can
convert
the
adenosine
in
double‐stranded
(dsRNA)
molecules
into
inosine
a
process
known
as
A‐to‐I
editing.
ADAR1
regulates
gene
expression
output
by
interacting
with
and
other
proteins;
plays
important
roles
development,
including
growth;
is
linked
to
innate
immunity,
tumors,
central
nervous
system
(CNS)
diseases.
Results
In
recent
years,
role
of
tumors
has
been
widely
discussed,
but
its
CNS
diseases
not
reviewed.
It
worth
noting
that
studies
have
shown
great
potential
treatment
neurodegenerative
diseases,
mechanisms
are
still
unclear.
Therefore,
it
necessary
elaborate
Conclusions
Here,
we
focus
effects
such
Aicardi–AicardiGoutières
syndrome,
Alzheimer's
disease,
Parkinson's
glioblastoma,
epilepsy,
amyotrophic
lateral
sclerosis,
autism.
We
also
evaluate
impact
ADAR1‐based
strategies
these
particular
development
new
technologies
microRNAs,
nanotechnology,
editing,
stem
cell
therapy.
hope
provide
directions
insights
for
future
editing
technology
brain
science
Journal of Biomaterials Science Polymer Edition,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 33
Published: Jan. 12, 2025
Infected
burn
wounds
present
significant
clinical
challenges
due
to
delayed
healing
and
risk
of
infection,
necessitating
advanced
treatments
that
offer
both
antimicrobial
regenerative
properties.
This
study
aimed
develop
evaluate
multifunctional
electrospun
nanofiber
films
incorporating
rhamnose
(as
an
angiogenic
agent)
therapeutic
agents,
namely
fluticasone,
mupirocin,
ciprofloxacin,
silver
sulfadiazine,
for
the
enhanced
infected
wounds.
Nanofibers
containing
rhamnose,
polyacrylonitrile,
polyvinyl
alcohol
agents
were
fabricated
via
electrospinning.
The
nanofibers
characterized
chemically
biologically.
FTIR
confirmed
successful
drug
incorporation,
while
XRD
indicated
a
reduced
crystallinity
in
drug-loaded
nanofibers.
SEM
analysis
revealed
bead
formation
some
formulations.
MTT
assays
demonstrated
moderate
cytotoxicity,
with
formulations
F2
(containing
all
components)
F4
components
except
sulfadiazine)
showing
activity
rhamnose.
Antibacterial
studies
superior
efficacy
F1
rhamnose)
against
Staphylococcus
aureus
Klebsiella
pneumoniae,
anti-inflammatory
highlighted
strong
ROS
inhibition
by
In
vivo
wound
14
days
showed
faster
closure
scarring
groups
treated
F1-F4,
particularly
those
multiple
active
achieving
up
30%
than
control
group.
exhibited
promising
antimicrobial,
anti-inflammatory,
wound-healing
properties,
making
them
potential
candidates
treating
Further
are
needed
optimize
clinical.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(18), P. 14044 - 14044
Published: Sept. 13, 2023
Alzheimer’s
disease
(AD)
is
a
progressive
neurodegenerative
that
affects
most
people
worldwide.
AD
complex
central
nervous
system
disorder.
Several
drugs
have
been
designed
to
cure
AD,
but
with
low
success
rates.
Because
the
blood–brain
and
blood–cerebrospinal
fluid
barriers
are
two
protect
system,
their
presence
has
severely
restricted
efficacy
of
many
treatments
studied
for
diagnosis
and/or
therapy.
The
use
nanoparticles
treatment
focus
an
established
rapidly
developing
field
nanomedicine.
Recent
developments
in
nanomedicine
made
it
possible
effectively
transport
brain.
However,
numerous
obstacles
remain
successful
nanomedicines
clinical
settings
treatment.
Furthermore,
given
rapid
advancement
therapeutics,
better
outcomes
patients
can
be
anticipated.
This
article
provides
overview
recent
using
different
types
management
AD.
Medicinal Research Reviews,
Journal Year:
2024,
Volume and Issue:
44(4), P. 1923 - 1966
Published: March 18, 2024
Over
the
past
few
decades,
there
has
been
a
notable
increase
in
global
burden
of
central
nervous
system
(CNS)
diseases.
Despite
advances
technology
and
therapeutic
options,
neurological
neurodegenerative
disorders
persist
as
significant
challenges
treatment
cure.
Recently,
remarkable
surge
interest
extracellular
vesicles
(EVs)
pivotal
mediators
intercellular
communication.
As
carriers
molecular
cargo,
EVs
demonstrate
ability
to
traverse
blood-brain
barrier,
enabling
bidirectional
result,
they
have
garnered
attention
potential
biomarkers
agents,
whether
their
natural
form
or
after
being
engineered
for
use
CNS.
This
review
article
aims
provide
comprehensive
introduction
EVs,
encompassing
various
aspects
such
diverse
isolation
methods,
characterization,
handling,
storage,
different
routes
EV
administration.
Additionally,
it
underscores
recent
applications
disorder
therapeutics.
By
exploring
unique
capabilities,
this
study
sheds
light
on
promising
future
clinical
research.
It
considers
inherent
limitations
these
emerging
while
incorporating
most
updates
field.
World Journal of Stem Cells,
Journal Year:
2023,
Volume and Issue:
15(7), P. 687 - 700
Published: July 24, 2023
Parkinson's
disease
(PD),
characterized
by
loss
of
nigrostriatal
dopaminergic
neurons,
is
one
the
most
predominant
neurodegenerative
diseases
affecting
elderly
population
worldwide.
The
concept
stem
cell
therapy
in
managing
has
evolved
over
years
and
recently
rapidly
progressed.
Neural
cells
(NSCs)
have
a
few
key
features,
including
self-renewal,
proliferation,
multipotency,
which
make
them
promising
agent
targeting
neurodegeneration.
It
generally
agreed
that
challenges
for
NSC-based
are
present
at
every
stage
transplantation
process,
preoperative
preparation
quality
control,
perioperative
procedures,
postoperative
graft
preservation,
adherence,
overall
success.
In
this
review,
we
provided
comprehensive,
careful,
critical
discussion
experimental
clinical
data
alongside
pros
cons
PD.
Given
state-of-the-art
accomplishments
therapy,
gene
nanotechnology,
shed
light
on
perspective
complementing
advantages
each
process
developing
nano-stem
currently
research
hotspot.
Although
various
obstacles
remain,
holds
promise
to
cure
PD,
however,
continuous
improvement
development
from
laboratory
experiments
application
necessary.
Ibrain,
Journal Year:
2023,
Volume and Issue:
9(3), P. 298 - 315
Published: Aug. 14, 2023
Abstract
Neurodegenerative
diseases
(NDs)
impose
substantial
medical
and
public
health
burdens
on
people
worldwide
represent
one
of
the
major
threats
to
human
health.
The
prevalence
these
age‐dependent
disorders
is
dramatically
increasing
over
time,
a
process
intrinsically
related
constantly
rising
percentage
elderly
population
in
recent
years.
Among
all
NDs,
Alzheimer's
Parkinson's
are
considered
most
debilitating
as
they
cause
memory
cognitive
loss,
well
severely
affecting
basic
physiological
conditions
such
ability
move,
speak,
breathe.
There
an
extreme
need
for
new
more
effective
therapies
counteract
devastating
diseases,
available
treatments
only
able
slow
down
pathogenic
without
really
stopping
or
resolving
it.
This
review
aims
elucidate
current
nanotechnology‐based
tools
representing
future
hope
NDs
treatment.
Noble
metal
nano‐systems,
that
is,
gold
silver
nanoparticles
(NPs),
have
indeed
unique
physicochemical
characteristics
enabling
them
deliver
any
pharmacological
treatment
way
within
central
nervous
system.
can
potentially
make
NPs
reversing
actual
therapeutic
strategy
based
slowing
irreversible
into
permanent
Discover Oncology,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: Dec. 21, 2024
Globally,
people
widely
recognize
cancer
as
one
of
the
most
lethal
diseases
due
to
its
high
mortality
rates
and
lack
effective
treatment
options.
Ongoing
research
into
therapies
remains
a
critical
area
inquiry,
holding
significant
social
relevance.
Currently
used
treatment,
such
chemotherapy,
radiation,
or
surgery,
often
suffers
from
other
problems
like
damaging
side
effects,
inaccuracy,
ability
clear
tumors.
Conventional
are
usually
imprecise
ineffective
develop
resistance
treatments
recurs.
Cancer
patients
need
fresh
innovative
that
can
reduce
effects
while
maximizing
effectiveness.
In
recent
decades
several
breakthroughs
in
these,
areas
medical
research,
have
paved
way
for
new
avenues
fighting
including
more
focused
alternatives.
This
study
reviews
exciting
possibilities
mesenchymal
stem
cells
(MSCs),
nanomaterials,
microbial
agents
modern
realm
treatment.
Nanoparticles
(NPs)
demonstrated
surprisingly
potential.
They
improve
drug
delivery
systems
(DDS)
significantly,
enhance
imaging
techniques
remarkably,
target
selectively
protecting
healthy
tissues.
MSCs
play
double
role
tissue
repair
vehicle
novel
gene
NPs
loaded
with
therapeutic
agents.
Additionally,
utilizing
agents,
particularly
those
involving
bacteria,
offer
an
inventive
approach
review
investigates
potential
MSCs,
addressing
shortcomings
conventional
therapies.
We
will
also
discuss
challenges
limitations
using
these
approaches.
Ibrain,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 22, 2025
Abstract
Neurodegenerative
diseases
(NDs)
are
disorders
that
drastically
alter
the
physiological
functioning
of
neurons
in
brain.
These
processes
often
accompanied
by
abnormal
protein
aggregates
physical
and
chemical
properties
brain
tissue
peripheral
nerves.
The
causes
NDs
complex,
involving
genetic
factors,
neuroinflammation,
oxidative
stress,
environmental
influences,
lifestyle,
while
symptoms
progression
vary
significantly
based
on
mechanisms
cell
death.
Currently,
no
definitive
treatment
exists
for
NDs,
as
underlying
degenerative
remain
poorly
understood.
Existing
therapies
focus
symptom
alleviation
but
insufficient
to
halt
or
prevent
disease
progression.
This
highlights
urgent
need
strategies
mimic
pathophysiology
facilitating
deeper
insights
development
effective
treatments.
Conventional
vitro
vivo
models
attempt
replicate
fail
capture
complexity
nervous
its
interactions.
In
this
context,
3D
microfluidic
bioprinting
emerges
a
transformative
technology.
By
enabling
precise
deposition
cells
biomaterials,
it
allows
creation
with
high
degree
structural
functional
complexity.
advancements
provide
valuable
platform
faithfully
modeling
bridging
critical
gaps
our
understanding,
paving
way
toward
innovative
therapeutic
approaches.